Search results

The World Council of Churches - Ecumenical Advocacy Alliance endorses a newly expanded collaboration on HIV between the Medicine Patent Pool and Gilead. On 4 October, the MPP announced a licence with Gilead Sciences for bictegravir, a new integrase inhibitor part of a once-daily, single-tablet HIV regimen currently filed for regulatory approval at the United States Food and Drug Administration and the European Union.

The Chernobyl disaster of 25 years ago remains a human and environmental tragedy so severe the consequences will continue for centuries. Its anniversary this week is especially timely given the current emergency in Japan which echoes some of Chernobyl’s hard lessons. To learn them would honour those who suffer from the past and could save lives in the future.